Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice

Molecular Psychiatry

Volumn 19, Issue 6, 2014, Pages 688-698

  Yu, Q ^a   Teixeira, C M ^a,b   Mahadevia, D ^a,b   Huang, Y ^a,c   Balsam, D ^a,b   Mann, J J ^a,c   Gingrich, J A ^a,b   Ansorge, M S ^a,b  

^a Howard Hughes Medical Institute   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

aggression; anxiety; depression; development; dopamine; serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMPHETAMINE; DOPAMINE; SEROTONIN; SEROTONIN TRANSPORTER; BRAIN MONOAMINE; MONOAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); CENTRAL NERVOUS SYSTEM AGENTS; DOPAMINE TRANSPORTER; NORADRENALIN TRANSPORTER; SLC6A4 PROTEIN, MOUSE;

ADULT; AFFECT; AGGRESSION; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG RESPONSE; EMOTIONAL DISORDER; EXPLORATORY BEHAVIOR; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; ISOLATION-INDUCED AGGRESSION TEST; LOCOMOTION; MALE; MOUSE; NEOPHOBIA; NONHUMAN; NOVELTY SUPPRESSED FEEDING TEST; OPEN FIELD TEST; OPTOGENETICS; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; ADOLESCENCE; ANIMAL TISSUE; ANXIETY; DOPAMINERGIC SYSTEM; MENTAL DEVELOPMENT; MONOAMINERGIC SYSTEM; NERVE CELL; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; 129 MOUSE; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; DEPRESSION; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

3,4-DIHYDROXYPHENYLACETIC ACID; AFFECT; AGGRESSION; AMPHETAMINE; ANIMALS; ANXIETY; BRAIN; CENTRAL NERVOUS SYSTEM AGENTS; DEPRESSION; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINERGIC NEURONS; FEMALE; MALE; MICE, 129 STRAIN; MONOAMINE OXIDASE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84901252706     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2014.10     Document Type: Article

References (68)

1. Ansorge MS, Hen R, Gingrich JA. Neurodevelopmental origins of depressive disorders. Curr Opin Pharmacol 2007; 7: 8-17.
2. Leonardo ED, Hen R. Anxiety as a developmental disorder. Neuropsychopharmacology 2008; 33: 134-140.
3. Beneyto M, Lewis DA. Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry. Int J Dev Neurosci 2011; 29: 295-304.
4. Hensch TK. Critical period regulation. Annu Rev Neurosci 2004; 27: 549-579.
5. Knudsen EI. Sensitive periods in the development of the brain and behavior. J Cogn Neurosci 2004; 16: 1412-1425.
6. Krishnan KR. Revisiting monoamine oxidase inhibitors. J Clin Psychiatry 2007; 68: 35-41.
7. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993; 262: 578-580.
8. Buckholtz JW, Meyer-Lindenberg A. MAOA and the neurogenetic architecture of human aggression. Trends Neurosci 2008; 31: 120-129.
9. Tadic A, Rujescu D, Szegedi A, Giegling I, Singer P, Moller HJ et al. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet B Neuropsychiatr Genet 2003; 117B: 1-6.
10. Karere GM, Kinnally EL, Sanchez JN, Famula TR, Lyons LA, Capitanio JP. What is an 'adverse' environment? Interactions of rearing experiences and MAOA genotype in rhesus monkeys. Biol Psychiatry 2009; 65: 770-777.
11. Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995; 268: 1763-1766.
12. Scott AL, Bortolato M, Chen K, Shih JC. Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport 2008; 19: 739-743.
13. Godar SC, Bortolato M, Frau R, Dousti M, Chen K, Shih JC. Maladaptive defensive behaviours in monoamine oxidase A-deficient mice. Int J Neuropsychopharmacol 2010; 14: 1-13.
14. Gaspar P, Cases O, Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003; 4: 1002-1012.
15. Homberg JR, Schubert D, Gaspar P. New perspectives on the neurodevelopmental effects of SSRIs. Trends Pharmacol Sci 2010; 31: 60-65.
16. Souza BR, Tropepe V. The role of dopaminergic signalling during larval zebrafish brain development: a tool for investigating the developmental basis of neuropsychiatric disorders. Rev Neurosci 2011; 22: 107-119.
17. Rebsam A, Seif I, Gaspar P. Refinement of thalamocortical arbors and emergence of barrel domains in the primary somatosensory cortex: a study of normal and monoamine oxidase a knock-out mice. J Neurosci 2002; 22: 8541-8552.
18. Cases O, Vitalis T, Seif I, De Maeyer E, Sotelo C, Gaspar P. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron 1996; 16: 297-307.
19. Vitalis T, Cases O, Callebert J, Launay JM, Price DJ, Seif I et al. Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period. J Comp Neurol 1998; 393: 169-184.
20. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004; 306: 879-881.
21. Ansorge MS, Morelli E, Gingrich JA. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice. J Neurosci 2008; 28: 199-207.
22. Chen K, Cases O, Rebrin I, Wu W, Gallaher TK, Seif I et al. Forebrain-specific expression of monoamine oxidase A reduces neurotransmitter levels, restores the brain structure, and rescues aggressive behavior in monoamine oxidase A-deficient mice. J Biol Chem 2007; 282: 115-123.
23. Hirate K, Kuribara H. Characteristics of the ambulation-increasing effect of GBR-12909, a selective dopamine uptake inhibitor, in mice. Jpn J Pharmacol 1991; 55: 501-511.
24. Backman CM, Malik N, Zhang Y, Shan L, Grinberg A, Hoffer BJ et al. Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus. Genesis 2006; 44: 383-390.
25. Madisen L, Mao T, Koch H, Zhuo JM, Berenyi A, Fujisawa S et al. A toolbox of Credependent optogenetic transgenic mice for light-induced activation and silencing. Nat Neurosci 2012; 15: 793-802.
26. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH et al. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 2003; 54: 960-971.
27. Underwood MD, Arango V, Bakalian MJ, Ruggiero DA, Mann JJ. Dorsal raphe nucleus serotonergic neurons innervate the rostral ventrolateral medulla in rat. Brain Res 1999; 824: 45-55.
28. Vitalis T, Fouquet C, Alvarez C, Seif I, Price D, Gaspar P et al. Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J Comp Neurol 2002; 442: 331-347.
29. de Almeida RM, Ferrari PF, Parmigiani S, Miczek KA. Escalated aggressive behavior: dopamine, serotonin and GABA. Eur J Pharmacol 2005; 526: 51-64.
30. Holmes A, Murphy DL, Crawley JN. Abnormal behavioral phenotypes of serotonin transporter knockout mice: parallels with human anxiety and depression. Biol Psychiatry 2003; 54: 953-959.
31. Richardson-Jones JW, Craige CP, Nguyen TH, Kung HF, Gardier AM, Dranovsky A et al. Serotonin-1A autoreceptors are necessary and sufficient for the normal formation of circuits underlying innate anxiety. J Neurosci 2011; 31: 6008-6018.
32. Rodriguiz RM, Chu R, Caron MG, Wetsel WC. Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res 2004; 148: 185-198.
33. Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA 1998; 95: 9991-9996.
34. Holmes A, Murphy DL, Crawley JN. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 2002; 161: 160-167.
35. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
36. Canli T, Lesch KP. Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci 2007; 10: 1103-1109.
37. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 2009; 301: 2462-2471.
38. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE. Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010; 167: 509-527.
39. Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011; 68: 444-454.
40. Schmidt LG, Sander T, Kuhn S, Smolka M, Rommelspacher H, Samochowiec J et al. Different allele distribution of a regulatory MAOA gene promoter polymorphism in antisocial and anxious-depressive alcoholics. J Neural Transm 2000; 107: 681-689.
41. Le Francois B, Czesak M, Steubl D, Albert PR. Transcriptional regulation at a HTR1A polymorphism associated with mental illness. Neuropharmacology 2008; 55: 977-985.
42. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW et al. Role of genotype in the cycle of violence in maltreated children. Science 2002; 297: 851-854.
43. Zalsman G, Huang YY, Harkavy-Friedman JM, Oquendo MA, Ellis SP, Mann JJ. Relationship of MAO-A promoter (u-VNTR) and COMT (V158M) gene polymorphisms to CSF monoamine metabolites levels in a psychiatric sample of caucasians: A preliminary report. Am J Med Genet B Neuropsychiatr Genet 2005; 132: 100-103.
44. Bedard AC, Schulz KP, Cook EH Jr., Fan J, Clerkin SM, Ivanov I et al. Dopamine transporter gene variation modulates activation of striatum in youth with ADHD. Neuroimage 2010; 53: 935-942.
45. Guo G, Roettger ME, Shih JC. Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. Hum Genet 2007; 121: 125-136.
46. Volavka J, Bilder R, Nolan K. Catecholamines and aggression: the role of COMT and MAO polymorphisms. Ann NY Acad Sci 2004; 1036: 393-398.
47. Colantuoni C, Lipska BK, Ye T, Hyde TM, Tao R, Leek JT et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519-523.
48. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 2000; 24: 417-463.
49. Dawe S, Davis P, Lapworth K, McKetin R. Mechanisms underlying aggressive and hostile behavior in amphetamine users. Curr Opin Psychiatry 2009; 22: 269-273.
50. Sokolov BP, Schindler CW, Cadet JL. Chronic methamphetamine increases fighting in mice. Pharmacol Biochem Behav 2004; 77: 319-326.
51. Martin SP, Smith EO, Byrd LD. Effects of dominance rank on d-amphetamineinduced increases in aggression. Pharmacol Biochem Behav 1990; 37: 493-496.
52. Sekine Y, Ouchi Y, Takei N, Yoshikawa E, Nakamura K, Futatsubashi M et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 2006; 63: 90-100.
53. Oberlander TF, Gingrich JA, Ansorge MS. Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence. Clin Pharmacol Ther 2009; 86: 672-677.
54. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders. Arch Gen Psychiatry 2011; 68: 1104-1112.
55. Crews F, He J, Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 2007; 86: 189-199.
56. Sullivan RM, Landers M, Yeaman B, Wilson DA. Good memories of bad events in infancy. Nature 2000; 407: 38-39.
57. Moriceau S, Sullivan RM. Maternal presence serves as a switch between learning fear and attraction in infancy. Nat Neurosci 2006; 9: 1004-1006.
58. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828-834.
59. Heinz A, Braus DF, Smolka MN, Wrase J, Puls I, Hermann D et al. Amygdalaprefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005; 8: 20-21.
60. Pellis SM, Pellis VC. The prejuvenile onset of play fighting in laboratory rats (Rattus norvegicus). Dev Psychobiol 1997; 31: 193-205.
61. Pellis SM, Pasztor TJ. The developmental onset of a rudimentary form of play fighting in C57 mice. Dev Psychobiol 1999; 34: 175-182.
62. Suomi SJ. Risk, resilience, and gene x environment interactions in rhesus monkeys. Ann N Y Acad Sci 2006; 1094: 52-62.
63. Moffitt TE. Adolescence-limited and life-course-persistent antisocial behavior: a developmental taxonomy. Psychol Rev 1993; 100: 674-701.
64. Persico AM, Mengual E, Moessner R, Hall FS, Revay RS, Sora I et al. Barrel pattern formation requires serotonin uptake by thalamocortical afferents, and not vesicular monoamine release. J Neurosci 2001; 21: 6862-6873.
65. Li H, Fertuzinhos S, Mohns E, Hnasko TS, Verhage M, Edwards R et al. Laminar and columnar development of barrel cortex relies on thalamocortical neurotransmission. Neuron 2013; 79: 970-986.
66. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Benning SD, Li R et al. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci 2010; 13: 419-421.
67. Andersen SL, Arvanitogiannis A, Pliakas AM, LeBlanc C, Carlezon WA Jr. Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nat Neurosci 2002; 5: 13-14.
68. Seo D, Patrick CJ, Kennealy PJ. Role of serotonin and dopamine system interactions in the neurobiology of impulsive aggression and its comorbidity with other clinical disorders. Aggress Violent Behav 2008; 13: 383-395.